 |
 |
North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group Stoke-on-Trent Clinical Commissioning Group
|
Formulary Chapter 5: Infections - Full Section
|
Notes:
Please note that Primary and Secondary Care have separate antimicrobial guidelines; Secondary Care utilises a UHNM Trust-specific antimicrobial formulary (note that the UHNM antimicrobial guidelines [microguide] can also be downloaded on smartphones).
These can be found at:
For Primary Care, the Antimicrobial Guidelines can be accessed on netFormulary via this link: 2019 STAFFORDSHIRE AND STOKE-ON-TRENT ANTIMICROBIAL PRESCRIBING GUIDELINES –MANAGING COMMON INFECTIONS IN PRIMARY CARE
For Secondary Care on the UHNM intranet by following: http://uhnm/clinicians/clinical-guidance/clinical-guidelines-and-pathways/antimicrobial/
Patients with HIV are treated according to the NICE accredited British HIV Association (BHIVA) guidelines which can be found at www.bhiva.org |
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
05.01 |
Antibacterial drugs
(0,0)
|
05.01.01 |
Penicillins
(0,0)
|
05.01.01.01 |
Benzylpenicillin and phenoxymethylpenicillin
(0,0)
|
05.01.01.02 |
Penicillinase-resistant penicillins
(0,0)
|
05.01.01.03 |
Broad-spectrum penicillins
(0,0)
|
05.01.01.04 |
Antipseudomonal penicillins
(0,0)
|
05.01.01.05 |
Mecillinams
(0,0)
|
05.01.02 |
Cephalosporins, carbapenems and other beta-lactums
(0,0)
|
05.01.02.01 |
Cephalosporins
(0,0)
|
05.01.02.02 |
Carbapenems
(0,0)
|
05.01.02.03 |
Other beta-lactums antibiotics
(1,0)
|
05.01.03 |
Tetracyclines
(0,0)
|
05.01.04 |
Aminoglycosides
(3,0)
|
05.01.05 |
Macrolides
(0,0)
|
05.01.06 |
Clindamycin
(0,0)
|
05.01.07 |
Some other antibacterials
(4,0)
|
05.01.08 |
Sulphonamides and trimethoprim
(0,0)
|
05.01.09 |
Antituberculosis drugs
(0,0)
|
05.01.10 |
Antileprotic drugs
(0,0)
|
05.01.11 |
Metronidazole and tinidazole
(0,0)
|
05.01.12 |
Quinolones
(1,0)
|
05.01.13 |
Urinary-tract infections
(3,0)
|
05.02 |
Antifungal drugs
(0,0)
|
05.02.01 |
Triazole antifungals
(0,0)
|
05.02.02 |
Imidazole antifungals
(0,0)
|
05.02.03 |
Polyene antifungals
(0,0)
|
05.02.04 |
Echinocandin antifungals
(0,0)
|
05.02.05 |
Other antifungals
(0,0)
|
05.03 |
Antiviral drugs
(0,0)
|
05.03.01 |
HIV infection
(1,0)
|
05.03.02 |
Herpesvirus infections
(0,0)
|
05.03.02.01 |
Herpes simplex and varicella-zoster infection
(0,0)
|
05.03.02.02 |
Cytomegalovirus infection
(1,0)
|
05.03.03 |
Viral hepatitis
(0,0)
|
05.03.03.01 |
Chronic hepatitis B
(3,0)
|
05.03.03.02 |
Chronic hepatitis C
(13,0)
|
05.03.04 |
Influenza
(2,0)
|
05.03.05 |
Respiratory syncytial virus
(0,0)
|
05.04 |
Antiprotozoal drugs
(0,0)
|
05.04.01 |
Antimalarials
(0,0)
|
05.04.02 |
Amoebicides
(0,0)
|
05.04.03 |
Trichomonacides
(0,0)
|
05.04.04 |
Antigiardial drugs
(0,0)
|
05.04.05 |
Leishmaniacides
(0,0)
|
05.04.06 |
Trypanocides
(0,0)
|
05.04.07 |
Drugs for toxoplasmosis
(0,0)
|
05.04.08 |
Drugs for pneumocystis pneumonia
(0,0)
|
05.05 |
Anthelmintics
(0,0)
|
05.05.01 |
Drugs for threadworms
(0,0)
|
05.05.02 |
Ascaricides
(0,0)
|
05.05.03 |
Drugs for tapeworm infections
(0,0)
|
05.05.04 |
Drugs for hookworms
(0,0)
|
05.05.05 |
Schistosomicides
(0,0)
|
05.05.06 |
Filaricides
(0,0)
|
05.05.07 |
Drugs for cutaneous larva migrans
(0,0)
|
05.05.08 |
Drugs for strongyloidiasis
(0,0)
|
|
|
|